Net sales for the first quarter of fiscal 2026 were $1,659.3 million, an increase of $5.2 million compared to the prior year quarter, including a favorable foreign currency impact of $23.7 million. Net sales at constant currency declined 1%, as a 6% increase in volume was offset by a 7% decline in price/mix. Adjusted EBITDA for the quarter was $302.2 million, representing a 1% increase compared to the prior year. Equity method investment results were a loss of $0.6 million for the first quarter of fiscal 2026, compared to earnings of $11.3 million in the same period of the prior year. The decline was attributed to lower net sales and an unfavorable mix of sales from unconsolidated joint ventures. Net cash provided by operating activities increased by $21.8 million to $352.0 million for the quarter. Capital returned to shareholders totaled $62.1 million in the quarter. The company reaffirmed its financial targets for fiscal 2026, including net sales at constant currency in the range of $6.35 billion to $6.55 billion, adjusted EBITDA between $1.00 billion and $1.20 billion, and approximately $500 million in capital expenditures.